Patients that frequently participate in multiple research studies to generate income may be a hazard to data quality and study results, and companies and organizations that sponsor clinical trials need to be prepared, according to recent studies of so-called professional patients.

from Forbes – Tech http://ift.tt/1ZQR3b2
via IFTTT